Introduction:

An adequate supply of medicines in health establishments will increase the possibility of adequate control of hypertension and diabetes.

Objective:

To determine the supply of antidiabetic and antihypertensive drugs at the national level in the context of the crisis by COVID-19.

Material y methods:

Analysis of the “Sistema Integrado de Suministro de Medicamentos e Insumos Médicos Quirúrgicos” (SISMED) Database, between June 13th and July 15th, 2020, according to the “National list for medicines of essential medicines” (PNUME) of Ministry of health.

Results:

Between 16% and 24% of the departments have a total shortage of at least one antidiabetic, and 4% and 96% of at least one antihypertensive. The most depleted antidiabetic was Metformin 500 mg, and the most depleted antihypertensive drugs were Labetalol 5 mg / ml iny, Atenolol 50 mg tab and Carvedilol 6.25 mg tab. The percentage of distribution was higher in hospitals and specialized institutes in comparison with primary health facilities.

Conclusions:

There is a shortage of antihypertensive and antidiabetic drugs in health centers in Peru.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )